Imatinib mesylate (Gleevec) hepatotoxicity

Ayse L. Mindikoglu, Arie Regev, Pablo A Bejarano, Enrique J. Martinez, Lennox J. Jeffers, Eugene R. Schiff

Research output: Contribution to journalArticle

24 Scopus citations
Original languageEnglish (US)
Pages (from-to)598-601
Number of pages4
JournalDigestive Diseases and Sciences
Issue number2
StatePublished - Feb 1 2007


  • CML
  • GIST
  • Gleevec
  • Hepatotoxicity
  • Imatinib mesylate

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mindikoglu, A. L., Regev, A., Bejarano, P. A., Martinez, E. J., Jeffers, L. J., & Schiff, E. R. (2007). Imatinib mesylate (Gleevec) hepatotoxicity. Digestive Diseases and Sciences, 52(2), 598-601.